在全身性红斑狼中治疗性向炎症性I型干扰素:有效性和不足,特别关注狼性炎
Benjamin Lai1, Shue-Fen Luo2, Jenn-Haung Lai2,3
1Department of Neurology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Frontiers in immunology
|October 31, 2024
概括
I型干扰素 (IFN-Is) 驱动全身性红斑狼 (SLE) 的病原发生. 虽然阻断IFN-I显得有前途,但由于IFN-I在性炎中的作用尚不清楚,因此需要进一步调查.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- I型干扰素 (IFN-Is) 参与了系统性红斑狼 (SLE) 的免疫病原发生.
- IFN-I诱导是由SLE的病原性事件触发的,IFN-I可以启动或加剧这些事件.
- 尽管IFN-I参与SLE,但IFN-I在狼性炎发病过程中的确切作用尚不清楚.
研究的目的:
- 审查IFN-I对SLE发育和免疫病原发生的贡献.
- 审查将IFN-I与狼性炎联系在一起的证据.
- 讨论抗IFN-I疗法,它们的有效性,以及SLE和狼性炎的未来前景.
主要方法:
- 发表的观察和临床试验的文献综述.
- 分析IFN-I在SLE免疫病原发生过程中的作用.
- 评估IFN-I与狼性炎的关联以及治疗策略.
主要成果:
- IFN-I在SLE病变发生过程中起着重要作用.
- 有证据表明IFN-I与狼性炎之间存在关联,尽管其对损伤的确切贡献仍在争论中.
- 抗IFN-I疗法在某些SLE表现方面表现出有效性,但对狼性炎仍然存在担忧.
结论:
- IFN-I是SLE的一个关键因素.
- 在狼性炎中针对IFN-I的作用和治疗益处需要进一步研究.
- 未来的研究应该澄清IFN-I对狼性炎的具体贡献,并优化抗IFN-I生物策略.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
Inflammatory Bowel Disease IV: Pharmacological Management
116
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
116
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
T Cell Types and Functions
954
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
954
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


